A 23-year-old female patient treated with 900 mg oxcarbazepine for complex partial seizures is presented. Good seizure control and slight fever were noted a few weeks after drug administration. Reduction of oxcarbazepine and replacement with valproate resulted in a transient normothermia. Because of fever reappearance, vigabatrin was added and valproate was gradually reduced. Seizures reappeared, but the body temperature fell below 37 • C. Substitution of valproate for lamotrigine resulted in seizure control but abnormal body temperature (37-37.6 • C) was noted again. Repeated hospital admission for clinical and laboratory investigation before any change of treatment revealed no other abnormal findings. The patient's abnormal temperature possibly reflects a derangement of high-level temperature control.
Introduction
During treatment with antiepileptic drugs mild or severe side-effects are not unusual 1 . Many of them are well known and have been classified. The appearance of a side-effect always poses the question of discontinuation of the responsible drug. The problem becomes more complicated when an extremely rare or unknown side-effect is present or when the patient takes more than one antiepileptic drug.
We present a 23-year-old female epileptic patient who developed a slight elevation of body temperature without other accompanying symptoms following treatment with oxcarbazepine, valproate and lamotrigine.
Case report
A 20-year-old female suffering from complex partial seizures since the age of 12 was admitted 3 years ago to our hospital. She had never received any antiepileptic treatment before.
A clinical and laboratory investigation was normal. Oxacarbazepine 300 mg × 2 daily for 2 weeks was administered; following that 300 mg × 3 daily. Routine biochemical and haematological screens that were done on the 5th, 26th and 46th days were normal. The patient complained of dysmenorrhoea and menstrual delay in the first months of the treatment. In addition, she reported a slight elevation of body temperature. She measured her body temperature almost every day for contraceptive reasons. Although her body temperature was 36.5-36.8 • C in the previous years, after treatment it reached over 37 • C. Measuring body temperature six times per day for 3 months confirmed these findings, and the patient was hospitalized and investigated for fever of unknown aetiology. The investigation did not reveal any abnormal findings.
A gradual reduction of oxcarbazepine and substitution for 1500 mg valproate was suggested. Gradually the temperature returned to pre-treatment levels; and she now had three to four simple seizures per month. Four months later she again noted temperatures over 37 • C (from 37 • C to 37.6 • C). She was again hospitalized for a detailed investigation which did not reveal any abnormal finding.
Valproate was reduced to 800 mg daily and vigabatrin (1500 mg) was added. She was seizure-free, although the body temperature was again abnormal. A further reduction of valproate resulted in gradual seizure reappearance.
S. Gatzonis et al. Lamotrigine was the next antiepilepic drug administered. Very good seizure control was achieved with up to 150 mg of lamotrigine and 2000 mg of vigabatrin daily. Gradually vigabatrin was withdrawn and the patient was almost seizure-free, but her temperature remained over 37 • C all this time. Thirty months later there was still no change (Fig. 1 ).
Discussion
Our patient had measured her temperature at 36.2 • C to 36.9 • C but not over 37 • C for 2 years before antiepileptic treatment. The abnormal measurements were noted 3 months after antiepileptic treatment administration. She did not complain of thermal discomfort or other symptoms.
The fever clearly appeared after oxcarbazepine administration, and lasted for almost 3 years in spite of therapy with four different antiepileptic drugs. No reports of fever as a side-effect after oxcarbazepine administration have been cited. Fever as an idiosyncratic side-effect has been reported for valproate or lamotrigine 2, 3 .
As has already been mentioned, the first and second extensive clinical and laboratory evaluations did not yield abnormal findings. A slow progressive subclinical illness is rather unlikely, as 30 months after the second hospitalization no other significant symptoms have been seen.
Because of the negative results of extended clinical and laboratory investigation and the absence of accompanying symptoms such as asthenia, fatigue or thermal discomfort, we now consider that our patient did not have 'fever' but a derangement of the 'set-point' around which body temperature is regulated.
There are heat and cold sensitive neurons in the brain which are capable of driving physiological and behavioral thermoregulatory responses in a way to keep a constant 'set-point' for body temperature.
There is some evidence for the influence of oxcarbazepine on the hypothalamus. Oxcarbazepine can produce hyponatremia, presumably by either increasing output of antidiuretic hormone or by influencing osmoreceptors 4 .
The influence of antiepileptic drugs on ion concentration is a possible underlying mechanism, as there are data which suggest that the physiological basis for the 'set-point' of temperature control is the inherent ratio of sodium to calcium ions in the posterior hypothalamus 5 . The drugs administered to the patient alter Na conductance.
It is also possible that AEDs may act on central action peptides with antipyretic properties or on central neurotransmitters influencing thermoregulation 6 . Wolf et al. (1964) reported periodic hyperthermia lasting 3 to 5 days and recurring once a week 7 . The basis for this disorder was not certain, but diencephalic epilepsy was considered a possibility. In our patient the steadiness of abnormal temperature eliminates the possibility of existence of an epileptic mechanism in central control areas responsible for the abnormal temperature. Moreover, abnormal temperature occurred in periods where seizure control was good.
Idiosyncratic cross-reaction to oxcarbazepine, valproate and lamotrigine seems to be extremely rare. In conclusion, no specific mechanism can be definitely identified for this persistent rise in temperature.
